Rhabdomyolysis Clinical Trial
Official title:
The Neuromuscular and Multisystem Features of RYR1-related Malignant Hyperthermia and Rhabdomyolysis - a Study Protocol
Rationale: Malignant hyperthermia and rhabdomyolysis are phenotypes that have long been considered to occur only in response to external stimuli (trigger anaesthesia and physical exhaustion) show several features of a continuous disease manifestation. Previous studies showed prolonged bleeding time after injury, selective immunological advantages, axial muscle weakness and several social difficulties. A detailed study of the neuromuscular and multisystem features of patients with RYR1-related malignant hyperthermia or rhabdomyolysis is needed to provide clarification about the continuous and multisystem disease manifestations in these patients. Objective: Primary Objective: There are three primary objectives in this study. 1. To investigate the neuromuscular involvement of RYR1 related MH and rhabdomyolysis. 2. To investigate the immunological changes in subjects with RYR1 related MH and rhabdomyolysis. 3. To identify multisystem features of RYR1 related MH and rhabdomyolysis. There are no secondary objectives. Study design: The design of the study will be a clinical, open, observational study. The study consists of three parts; a clinical, imaging and immunological part. Study population: Patients with a history of malignant hyperthermia susceptibility (MHS), and/or a history of rhabdomyolysis related to a variant in RYR1. Intervention (if applicable): Not applicable. Main study parameters/endpoints: The study consists of three parts. Each part has it's own main study parameters 1. Clinical part: the results of the questionnaire study compared to standardizes normal values and the results of the comprehensive clinical assessment. 2. Imaging part: fatty infiltration and hypertrophy of proximal and axial muscles. 3. Immunological part: circulating and leukocyte released anti- and pro-inflammatory cytokine levels compared to healthy age and sex matched controls.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03737513 -
Exercise-induced Collective Rhabdomyolysis
|
||
Completed |
NCT00241748 -
Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event
|
N/A | |
Not yet recruiting |
NCT02498366 -
Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty
|
N/A | |
Not yet recruiting |
NCT06429982 -
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
|
Phase 1 | |
Active, not recruiting |
NCT06101680 -
RhabdomYolyse in Intensive caRe
|
||
Withdrawn |
NCT02896517 -
Support for the Rhabdomyolysis in an Emergency Department
|
||
Completed |
NCT01467180 -
Myoglobin Removal by High Cut-off CVVHD
|
N/A | |
Recruiting |
NCT01022450 -
Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
|
N/A | |
Completed |
NCT00391911 -
Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis
|
Phase 2 | |
Withdrawn |
NCT02111018 -
Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis
|
Phase 2 | |
Completed |
NCT04913298 -
Prospective Study for the Application of Cytosorb® in Critically Ill Patients
|
N/A | |
Recruiting |
NCT05146336 -
CytOSorb TreatMent Of Critically Ill PatientS Registry
|
||
Completed |
NCT03986736 -
Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
|
||
Not yet recruiting |
NCT02518724 -
The Effect of Remote Ischemic Preconditioning on Physical Performance and Exertional Rhabdomyolysis
|
N/A | |
Completed |
NCT02671604 -
Rhabdomyolysis and Robot-assisted Radical Prostatectomy
|
N/A | |
Completed |
NCT00592657 -
Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions
|
N/A | |
Completed |
NCT06338423 -
Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure
|
N/A | |
Completed |
NCT01976936 -
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
|
Phase 2 | |
Completed |
NCT04118608 -
Rhabdomyolysis - a Study of Patient Characteristics and Laboratory Values to Guide Treatment
|
||
Completed |
NCT01544231 -
Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis
|
N/A |